Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actelion, Astrazeneca, Bluebird, Boehringer, Exelixis, GSK, Harbour, Imbrium, Immutep, Incyte, Intra-Cellular, Kiniksa, Levo, Lilly, Prothena, Neoimmunetech, Regeneron, Regenxbio, Roche, Saniona, Sojournix, Tersera, UCB, United Therapeutics.